Cite Filings / DNLI / 0001714899-21-000054
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

Denali Therapeutics Inc. · Filed 2021-05-05 · Acc 0001714899-21-000054

Documents 1

  • 10-Q Quarterly Report , dnli-20210331.htm

Around this filing

  • 2021-08-04 10-Q Quarterly Report
  • 2021-05-06 4 COO and Secretary sold 10,000 shares at an average $55.49 ($554,864)
  • 2021-05-05 10-Q Quarterly Report
  • 2021-05-05 4 Director sold 3,237 shares at an average $60.11 ($194,589)
  • 2021-05-05 4 President and CEO sold 18,333 shares at an average $58.64 ($1,075,102)
  • 2021-05-03 8-K Results of operations
  • 2020-11-05 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading dnli-20210331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…